相关实验视频
Updated: Jun 9, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
16.5K
基于蛋白质的纳米盘在癌症药物输送中的注射剂:从基板到临床潜力
Vimal Patel1, Jigar N Shah2, Saloni Dalwadi3
1Department of Pharmaceutics, School of Pharmacy, P P Savani University, Surat, 394125, Gujarat, India.
AAPS PharmSciTech
|October 31, 2025
概括
蛋白质纳米盘 (NDs) 通过模仿细胞膜来输送药物和核酸,为癌症治疗提供了一种新的方法. 这些纳米结构通过向癌细胞来增强药物的疗效并减少副作用.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 蛋白质纳米盘 (NDs) 是纳米级的结构,具有两层脂质和支架蛋白质,模仿细胞膜.
- 它们作为研究膜蛋白的平台,并已成为用于输送癌症药物的纳米配方.
研究的目的:
- 审查膜模拟蛋白质纳米盘在癌症治疗中的潜力.
- 讨论它们的结构成分,稳定性,合成,局限性和临床影响.
主要方法:
- 对用于癌症治疗的蛋白质纳米光盘现有文献的综述.
- 对纳米盘结构,稳定性和功能化策略的分析.
- 评估治疗进步和未来的挑战.
主要成果:
- NDs可以通过针对特定癌细胞结合的向配体进行功能化.
- ND配方保护大分子,增强药理动力学,并使药物释放得到控制.
- 无核试验显示了提高治疗效率和降低毒性的潜力.
结论:
- 膜模仿蛋白质纳米盘是瘤学中宏分子输送的多功能平台.
- 需要进一步的研究来解决稳定性,合成和临床翻译的挑战.
- 无核细胞对精确的癌细胞向和增强治疗结果具有前途.
相关概念视频
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

